This Week's Poll

At the recent BioPartner Forum it was stated the internal market is insufficient for a UK Life Science company to develop a technology, product or service at a rate that will return investor value. Do you

Supported by Medilink UK

NHS procurements routes - Richard Stone of - MedilinkWM - 9:19:56am Sep-12th

If there were a mechanism for easily identifying the procurement route within the NHS for a particular product, more companies would be able to achieve UK sales and not have to spend so much resource targeting overseas markets.

Agree/Disagree + add comment

Matthew Harte of - Protomed - 9:36:41am Mar-23rd

This is an age old argument with no satisfactory outcome. Given the huge nature of the NHS and the lack of purchasing structure, I'm not sure that this is possible. It would be nice though but may result in huge job savings of trust based purchasing teams.

 
 
t